↓ Skip to main content

A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.

Overview of attention for article published in Diabetology & Metabolic Syndrome, June 2014
Altmetric Badge

Mentioned by

twitter
2 tweeters

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.
Published in
Diabetology & Metabolic Syndrome, June 2014
DOI 10.1186/1758-5996-6-73
Pubmed ID
Authors

Orme M, Fenici P, Lomon ID, Wygant G, Townsend R, Roudaut M

Abstract

To compare the first-in-class sodium glucose co-transporter 2 (SGLT2) inhibitor, dapagliflozin, with existing type 2 diabetes mellitus (T2DM) treatment options available within the European Union (EU) for add-on therapy to sulfonylureas (SUs).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United States 1 1%
Unknown 65 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 19%
Researcher 9 13%
Student > Ph. D. Student 8 12%
Other 8 12%
Student > Bachelor 7 10%
Other 16 24%
Unknown 6 9%
Readers by discipline Count As %
Medicine and Dentistry 39 58%
Pharmacology, Toxicology and Pharmaceutical Science 7 10%
Agricultural and Biological Sciences 4 6%
Economics, Econometrics and Finance 2 3%
Social Sciences 2 3%
Other 6 9%
Unknown 7 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2014.
All research outputs
#3,056,557
of 4,507,509 outputs
Outputs from Diabetology & Metabolic Syndrome
#139
of 203 outputs
Outputs of similar age
#72,640
of 109,252 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#12
of 16 outputs
Altmetric has tracked 4,507,509 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 203 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,252 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.